Skip to main content
Intra-Cellular Therapies, Inc. (ITCI)
131.87
0.00 (0.00%)
Inactive · Last trade price on Apr 1, 2025

Intra-Cellular Therapies Revenue

In the year 2024, Intra-Cellular Therapies had annual revenue of $680.85M with 46.62% growth. Intra-Cellular Therapies had revenue of $199.22M in the quarter ending December 31, 2024, with 50.81% growth.

Revenue (ttm)
$680.85M
Revenue Growth
+46.62%
P/S Ratio
19.97
Revenue / Employee
$791,688
Employees
860
Market Cap
14.02B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024680.85M216.48M46.62%
Dec 31, 2023464.37M214.06M85.51%
Dec 31, 2022250.31M166.51M198.69%
Dec 31, 202183.80M60.99M267.35%
Dec 31, 202022.81M22.75M37,537.14%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ITCI News

More News